MedPath

Emotions, Dopamine, Brain and Body

Phase 4
Recruiting
Conditions
Emotions
Interventions
Drug: Domperidon
Drug: Placebo
Registration Number
NCT06171087
Lead Sponsor
German Institute of Human Nutrition
Brief Summary

The study will examine the influence of domperidon (20mg) on brain and hebavioral responses to emotional stimuli (videos) using fMRI

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
DomperidonDomperidonParticipants recieve 10mg of Domperidon, 45 minutes before the start of the experiment
PlaceboPlaceboParticipants recieve a placebo pill, 45 minutes before the start of the experiment
Primary Outcome Measures
NameTimeMethod
Brain responses to emotions1-3 hour after drug administratrion

fMRI brain responses to emotional videos comparing placebo vs domperidon condition. Specifically: dampened brain response to disgust and high arousing videos in domperidon condition

Body (stomach, heart, skin conductance) response to emotions1-3 hour after drug administratrion

Physiological responses to emotional videos comparing placebo vs domperidon condition. Specifically: Reduction in Tachyhastria for disgust and high arousing videos in domperidone condition

Behavioral responses to emotions1-3 hour after drug administratrion

Changes in subjective reports to emotional videos comparing placebo vs domperidon condition. Specifically: Reduction in disgust and arousal ratings to disgust and high arousing videos

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

German Institute of Human Nutrition

🇩🇪

Potsdam, Brandenburg, Germany

© Copyright 2025. All Rights Reserved by MedPath